Home » Topics » BioWorld Science

BioWorld Science
RSS

LBX2 is a marker of colon adenocarcinoma

Jan. 24, 2022

Tevogen to study allogeneic T-cell technology for Epstein-Barr virus and MS

Jan. 21, 2022

M1 muscarinic receptor mutant mice show accelerated prion neurodegeneration

Jan. 21, 2022

Alzinova selects humanized lead candidate of monoclonal antibody ALZ-201

Jan. 21, 2022

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Jan. 21, 2022

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Jan. 21, 2022

Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer

Jan. 21, 2022

Targeting HO-1 signaling pathway against dengue hemorrhagic fever

Jan. 21, 2022

Researchers develop novel murine model of age-related macular degeneration

Jan. 21, 2022

Gene silencing using Toc-HDO technology ameliorated symptoms in EAE models

Jan. 21, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...